NewsBenzinga일라이 릴리, 중국 최초 GLP-1 체중 감량 알약 승인 획득···잠재적 45억 달러 시장에서 선점 우위 확보: 보도 일라이 릴리, 중국 최초 GLP-1 체중 감량 알약 승인 획득···잠재적 45억 달러 시장에서 선점 우위 확보: 보도 Benzinga 2026.11.12 13:30 (GMT+0) Open on Benzinga Other news New Address Withdraws 1.344 Billion PUMP From Coinbase, Worth About $3.87 Million Key Overnight and Morning News (November 16–17) Crypto Sectors Trade Mixed as DeFi Rises 1.67% While RWA and GameFi Each Drop Over 2% AI Lab Noeri, Founded by Stanford Professors, Raises $110M With Nvidia Among Investors Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC
Baidu Q3 Earnings: Total Revenue 30.8 Billion Yuan, AI Business Revenue Share Above Half for Third Straight Quarter
Bitcoin, XRP, Dogecoin Slide, Ethereum Steady as ‘Extreme Fear’ Persists: Analyst Says ‘Selling Hasn’t Stopped Yet’ as Whales Offload BTC